清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Disease trajectories in childhood atopic dermatitis

特应性皮炎 医学 疾病 哮喘 过敏 儿科 幼儿 家族史 过敏性 免疫学 病理 发展心理学 外科 心理学
作者
Alan D. Irvine,Paola Mina‐Osorio
出处
期刊:British Journal of Dermatology [Wiley]
卷期号:181 (5)
标识
DOI:10.1111/bjd.18488
摘要

Eczema (also known as atopic dermatitis or AD) is a complex skin condition that generally develops in early childhood, affecting 15 to 20% of children worldwide. Although it clears by itself in some children, it persists into adulthood in many children, contrary to popular belief. Many children develop related allergic diseases such as asthma, allergic rhinitis and eosinophilic oesophagitis (allergic inflammation of the oesophagus), a pathway known as the “atopic march”. The authors, based in Ireland and the U.S.A., aimed to find reproducible patterns (i.e. clinically relevant characteristics) that could help doctors predict whether childhood AD will clear or progress, by surveying several recent studies with large patient cohorts (groups studied). These studies show that most atopic children, in fact, do not follow the classical “atopic march” but can follow various disease courses. Although the data came from different sources or were described in different ways, the authors identified common characteristics of early‐childhood AD that may help estimate risk of developing persistent disease (i.e. that progresses into adulthood) and related allergic diseases. They found that children who get severe AD at a very young age and who have parents with a history of related diseases, have a higher risk of disease progression. Genetic factors, allergies, and living in an urban environment also increase this risk. The authors provide a practitioner's guide that could help doctors to identify children with AD at higher risk of disease progression and to decide on the best course of action for their treatment, such as regular check‐ups or referring them to a specialist for further testing or treatment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
懒得起名字完成签到 ,获得积分10
9秒前
vinni完成签到 ,获得积分10
29秒前
胡国伦完成签到 ,获得积分10
36秒前
widesky777完成签到 ,获得积分0
1分钟前
追寻的不言完成签到,获得积分10
1分钟前
ding应助科研通管家采纳,获得10
1分钟前
1分钟前
Jasperlee完成签到 ,获得积分10
1分钟前
欧尼酱完成签到 ,获得积分10
1分钟前
冷傲的擎汉完成签到 ,获得积分10
2分钟前
文艺完成签到,获得积分10
2分钟前
2分钟前
文艺发布了新的文献求助10
2分钟前
mzhang2完成签到 ,获得积分10
2分钟前
美好灵寒完成签到 ,获得积分10
3分钟前
3分钟前
Hello应助科研通管家采纳,获得10
3分钟前
倾卿如玉完成签到 ,获得积分10
3分钟前
sjfczyh发布了新的文献求助10
4分钟前
管靖易完成签到 ,获得积分10
4分钟前
bkagyin应助Cloud采纳,获得10
4分钟前
orixero应助sjfczyh采纳,获得10
4分钟前
4分钟前
Cloud发布了新的文献求助10
4分钟前
4分钟前
郭强完成签到 ,获得积分10
4分钟前
sjfczyh发布了新的文献求助10
5分钟前
合不着完成签到 ,获得积分10
5分钟前
jlwang完成签到,获得积分10
5分钟前
黑猫老师完成签到 ,获得积分10
5分钟前
科研通AI2S应助科研通管家采纳,获得10
5分钟前
5分钟前
666发布了新的文献求助10
5分钟前
5分钟前
5分钟前
尼克狐尼克完成签到,获得积分10
5分钟前
5分钟前
兼听则明完成签到,获得积分10
6分钟前
开心每一天完成签到 ,获得积分10
6分钟前
chichenglin完成签到 ,获得积分0
6分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Kinesiophobia : a new view of chronic pain behavior 3000
Les Mantodea de guyane 2500
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 2000
Standard: In-Space Storable Fluid Transfer for Prepared Spacecraft (AIAA S-157-2024) 1000
Signals, Systems, and Signal Processing 510
Discrete-Time Signals and Systems 510
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5950598
求助须知:如何正确求助?哪些是违规求助? 7137698
关于积分的说明 15918262
捐赠科研通 5084312
什么是DOI,文献DOI怎么找? 2733219
邀请新用户注册赠送积分活动 1694530
关于科研通互助平台的介绍 1616168